A holiday weekend miscellany for our dear Irregulars
21 Comments Read MoreArticles
Friday File: Botox Competitor, NVIDIA, Shopify and Thrift Conversions
Another Look at the Current Migraine Scene
Thinking about COVID-19 almost gives me a migraine, or at least a heavy and achy sensation in my noggin – perhaps not an actual migraine, thankfully, but threatening and unpleasant all the same. Happily, thinking about migraines will not give me COVID-19. But migraines are by no means a topic of no consequence, […]
13 Comments Read MoreMostly Non-COVID-19 Related Miscellany
Some updates from Doc Gumshoe on Hydroxychloroquine, Aspirin for cancer, stem cells for Parkinson's and CRISPR for blindness
28 Comments Read MoreFriday File: Markman’s $5 “Next Cisco”
What's the teased "$5 Stock Set To Grow 18x In The Tiny Supercomputers Revolution?"
10 Comments Read MoreAltucher’s Feb. 17 Deadline “Windfall Profit Opportunity” from a “Tiny California Biotech”
What's being promoted as "“The Greatest Biotech Opportunity of the Decade” in ads for Microcap X Advisory? Their special report is called "Windfall Profits: Biotech’s Next 54,600% Medical Breakthrough"
76 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I have been a member for two years 2018 only cleared 8 % on his recommendations This year 80% of his weekly recomme...
Long $SNDX eflyonthewall.com: Syndax enters worldwide license agreement with Vitae Pharmaceuticals Syndax Pharmaceuti...
$JNJ, VRX, ABT, AGN, NSRGY, NVS I own shares of AGN$JNJ has agreed to acquire AMO (Abbott Medical Optics) for $4....
Allergan (AGN) completes huge deal with Teva.https://biz.yahoo.com/e/160804/agn8-k.htmlCheers,Glenn...
Incyte $INCY looks like a worthy alluring takeover candidate here to me. I suspect it's on a shopping list at both Aller...
I am wondering if any readers have a sense of what Carl Icahn may be up to with his new large stake in Allergan $AGN. ...
Teva to drop bid for Mylan, and instead is buying the generics drug business of Allergan $AGN (formerly Actavis). Deal p...
To Lou L: You asked some good questions about Revance and about Kindred. I knew something of them from their recent IPO'...